首页> 美国卫生研究院文献>Journal of Enzyme Inhibition and Medicinal Chemistry >Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues
【2h】

Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues

机译:加州鱼雷乙酰胆碱酯酶与两个类似多奈哌齐的刚性类似物相互作用的动力学和结构研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acetylcholinesterase inhibitors were introduced for the symptomatic treatment of Alzheimer’s disease (AD). Among the currently approved inhibitors, donepezil (DNP) is one of the most preferred choices in AD therapy. The X-ray crystal structures of Torpedo californica AChE in complex with two novel rigid DNP-like analogs, compounds >1 and >2, have been determined. Kinetic studies indicated that compounds >1 and >2 show a mixed-type inhibition against TcAChE, with Ki values of 11.12 ± 2.88 and 29.86 ± 1.12 nM, respectively. The DNP rigidification results in a likely entropy-enthalpy compensation with solvation effects contributing primarily to AChE binding affinity. Molecular docking evidenced the molecular basis for the binding of compounds >1 and >2 to the active site of β-secretase-1. Overall, these simplified DNP derivatives may represent new structural templates for the design of lead compounds for a more effective therapeutic strategy against AD by foreseeing a dual AChE and BACE-1 inhibitory activity.
机译:引入乙酰胆碱酯酶抑制剂用于对症治疗阿尔茨海默氏病(AD)。在目前批准的抑制剂中,多奈哌齐(DNP)是AD治疗中最优选的选择之一。确定了带有两种新型DNP刚性类似物化合物> 1 和> 2 的加利福尼亚鱼雷AChE的X射线晶体结构。动力学研究表明,化合物> 1 和> 2 显示出对TcAChE的混合型抑制作用,Ki值分别为11.12±2.88和29.86±1.12nM。 DNP硬化导致可能产生的熵焓补偿,而溶剂化效应主要有助于AChE结合亲和力。分子对接为化合物> 1 和> 2 与β-分泌酶-1的活性位点结合提供了分子基础。总体而言,这些简化的DNP衍生物可能代表用于设计先导化合物的新结构模板,从而通过预见AChE和BACE-1的双重抑制活性而更有效地治疗AD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号